Nurse-pharmacist collaborations for promoting medication safety among community-dwelling adults: A scoping review

Nurse-pharmacist collaborations for promoting medication safety among community-dwelling adults: A scoping review

Background: Despite good evidence that supports improved clinical health outcomes and the cost effectiveness of nurse-pharmacist collaboration for promoting medication safety among adults in acute care settings, there is limited research in community settings. Objective: This scoping review examines...

Full description

Bibliographic Details
Main Authors:	Padma Ravi, Kathryn Pfaff, Jody Ralph, Edward Cruz, Mackenzie Bellaire, Gemma Fontanin
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	International Journal of Nursing Studies Advances
Subjects:	Chronic disease Self-management Drug-related side effects and adverse reactions Disease management Outcome assessment Health care
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666142X22000182

Similar Items

Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers
by: Mohamed Bahlol, et al.
Published: (2022-07-01)

RESIDUAL VOLUME OF AMPOULE-VIALS AND UNDERDOSING OF MEDICATIONS PREPARED BY A NURSING STAFF
by: Francine Rodrigues Witkouskas, et al.
Published: (2022-08-01)

Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan
by: Ryuta Urakawa, et al.
Published: (2022-08-01)

Medical and Surgical Complications in Three Tertiary Hospitals in the Northeast of Iran: A Multicenter Study
by: Masoumeh Sarbaz, et al.
Published: (2019-06-01)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
by: Maria Katarine Costa Lucas Gontijo, et al.
Published: (2020-01-01)

The Impact of Pharmacist-Led Medication Management Services on the Quality of Life and Adverse Drug Reaction Occurrence
by: Andrea Brajković, et al.
Published: (2022-08-01)

Intervenciones educacionales para incrementar la farmacovigilancia en una unidad de salud de familia
by: Ana Rita Ribeiro Barbosa, et al.
Published: (2022-09-01)

Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns
by: Maliheh Hamidian, et al.
Published: (2022-01-01)

Factors related to technical management and adverse drug event reporting in independent retail pharmacies in Cali, Colombia
by: Jobany Castro Espinosa, et al.
Published: (2022-03-01)

The Significance of the Ocular Adverse Effect Induced by Systemic Taxane Application
by: Ya-Ting Ye, et al.
Published: (2022-05-01)

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review
by: Lee S. Nguyen, et al.
Published: (2021-02-01)

Implementation of a Pharmacist-Directed Cardiovascular Risk and Medication Management Program for Participants in a Construction Trade Benefit Trust Fund
by: Yifei Liu, PhD, et al.
Published: (2010-01-01)

Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: a systematic review
by: Sai Krishna Gudi, et al.
Published: (2019-05-01)

Integrating home-based tele-monitoring in disease management (DM) program for community-dwelling patients with chronic heart failure (CHF)
by: G. Kaufman, et al.
Published: (2011-06-01)

Heterogeneous Collaborative Sensor Network for Electrical Management of an Automated House with PV Energy
by: Javier Jiménez-Leube, et al.
Published: (2011-12-01)

Possible Negative Effects of Psychotherapies
by: I. Volkan Gulum
Published: (2012-12-01)

On the definition of infodemic and the role of librarians: a conversation with Tina Purnat of WHO
by: Matilde Fontanin
Published: (2023-05-01)

De novo podocytopathy following moderna COVID-19 vaccine: A case report and racial disproportionality in adverse effect reports
by: Li-Yu Hong, et al.
Published: (2022-08-01)

Ocular adverse events from pharmacological treatment in patients with multiple sclerosis—A systematic review of the literature
by: Juliana Muñoz-Ortiz, et al.
Published: (2021-10-01)

Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data
by: Elena Ramírez, et al.
Published: (2020-12-01)

Pharmacist Intervention in Portuguese Older Adult Care
by: Ana Rita Rodrigues, et al.
Published: (2022-09-01)

Safety of pre-incisional low-dose ropivacaine infiltration in bilateral axillo-breast approach thyroidectomy: a retrospective study
by: Anna Cho, et al.
Published: (2022-11-01)

Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
by: Emmerton Lynne M, et al.
Published: (2012-06-01)

Pharmacist Provided Spirometry Services: A Scoping Review
by: Valentino AS, et al.
Published: (2021-08-01)

Burnout and patient safety: A discriminant analysis of paediatric nurses by low to high managerial support
by: Haitham Khatatbeh, et al.
Published: (2021-03-01)

Management of Point-of-Care Testing (POCT) Services by Community Pharmacists in Osun State Nigeria
by: Maduabuchi Romanus Ihekoronye, et al.
Published: (2023-09-01)

Pharmacy practice in hospital settings in GCC countries: Pharmacists’ medication therapy monitoring activities
by: Ahmed H. Al-jedai, et al.
Published: (2024-02-01)

Inappropriate Medication Use in Hospitalized Patients Diagnosed with Parkinson’s Disease
by: Nicholas Cox, et al.
Published: (2018-09-01)

DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE
by: Amanda Roseane Farias do Nascimento, et al.

Acute Confusional State after Inhaled Corticotherapy
by: Mário Castro Marques dos Santos, et al.
Published: (2018-07-01)

Manifestaciones cutáneas de la enfermedad inflamatoria intestinal
by: José David Puerta Rojas, et al.
Published: (2021-10-01)

WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS?
by: Yu. V. Muravyev, et al.
Published: (2017-04-01)

USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TERMS OF FOETUS SAFETY: ANALYSIS OF PRESCRIBINGS
by: A. P. Pereverzev, et al.
Published: (2022-06-01)

PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS
by: E. J. Kolesnikova
Published: (2022-06-01)

Reversible cycloplegia caused by duloxetine: a case report
by: Rabia Nazik Yüksel, et al.
Published: (2017-07-01)

Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
by: Saralinh Trinh, et al.
Published: (2019-01-01)

Percepción entre médicos bogotanos del riesgo de reacciones adversas a grupos de medicamentos de uso común
by: Jefferson Antonio Buendia, et al.
Published: (2014-09-01)

Serum potassium level used as trigger doubled the detection of adverse drug events when compared with calcium polystyrene sulfonate trigger: a cross-sectional study
by: Patricia de Carvalho Mastroianni, et al.
Published: (2021-05-01)

Serum potassium level used as trigger doubled the detection of adverse drug events when compared with calcium polystyrene sulfonate trigger: a cross-sectional study
by: Patricia de Carvalho Mastroianni, et al.
Published: (2021-05-01)

Role of pharmacist in the management of Hansen's Disease: A scoping review
by: Elza Cristina de Oliveira Duarte, et al.
Published: (2023-12-01)